This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Cellular phone use began in the United Kingdom in 1985. Sales increased slowly until 1992, more rapidly to 1997, before substantial growth to 2005 (figure).1 The UK Stewart Report2 into cellular phones and health concluded: “It is not possible at present to say that exposure to radio frequency radiation, even at levels below national guidelines, is totally without potential adverse health effects, and that the gaps in knowledge are sufficient to justify a precautionary approach.”
Figure. Active UK cellular phone subscriptions, 1984 to 2004 (right scale), and age-standardized rate* of acoustic neuroma and other benign cranial nerve neoplasms among people of all ages in England and Wales, 1979 to 2001 (left scale). *Directly age standardized using the European standard population; 3-year moving averages.
A recent case-control study from Sweden found up to fourfold risk associated with cellular phone use of 10 or more years’ duration.3 A number of studies both in Europe and the United States have found little or no evidence of an effect,4 and a recent report from five countries suggests …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas
Evaluation of clinical diagnostic criteria for neurofibromatosis 2
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis
Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials